General Range
ITRATUNE SB
Price on request/100 · MOQ 100 boxes
ITRATUNE SB Capsules by Fortune Labs contain Itraconazole 130 mg, a super bioavailable antifungal formulation designed to improve drug absorption. Itraconazole belongs to the triazole antifungal class and works by inhibiting ergosterol synthesis, disrupting fungal cell membranes and controlling fungal growth. ITRATUNE SB may be prescribed for selected fungal skin infections, including ringworm, athlete's foot, and jock itch, when clinically appropriate. Available in convenient 10 × 10 capsule blister packaging, this product is part of Fortune Labs' dermatology pharmaceutical portfolio. Fortune Labs offers Derma PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use only under medical supervision due to potential liver, heart, and drug interaction risks.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Itraconazole 130 mg (Super Bioavailable Formulation
- Packaging Type
- Blister Pack with Outer Carton
- Packaging Size
- 10 × 10
- Dosage Form
- Capsules
- Treatment
- Fungal skin infections, ringworm (Tinea Corporis), athlete's foot (Tinea Pedis), jock itch (Tinea Cruris), and other susceptible fungal infections whe
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
